Newsroom
August 11, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, and Claudia Satizabal, PhD, Population Health Sciences and the Glenn Biggs Institute, were quoted in this story. Read More
August 1, 2023
Okeanis Vaou, MD, FAAN, Neurology, was quoted in this article. Read More
July 31, 2023
Yannick Ngouongo, PhD, postdoctoral research fellow, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was quoted in this story. Read More
July 31, 2023
Jazmyn Sherrae Muhammad, BS, research associate, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was interviewed at the Alzheimer’s Association International Conference for this video. Watch Now
July 30, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was featured in this story. Read More
July 27, 2023
Volunteers 50 to 89 with a diagnosis of mild cognitive impairment or probable mild AD may ask about eligibility to participate in VIVA-MIND, a study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.
